Glimmers of hope for MDR-Tuberculosis treatment
The Lancet Respiratory Medicine in conversation with - En podcast av The Lancet Group
Kategorier:
Dr Raj Gupta discusses the potential of delaminid, one of the first new TB drugs to enter the market in 40 years, to offer new hope for treatment of multi drug resistant tuberculosis. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
